Panosome GmbH – a parasite as the basis for innovative immunotherapies - 26/08/2026

Reaching the unreachable: new approaches to challenging drug targets

Modern medicines act with remarkable precision. Antibodies, for example, recognise their molecular targets much like a key fits into its corresponding lock. However, certain targets like small molecules or carbohydrates remain difficult to target. The start-up Panosome aims to eliminate these blind spots with a novel immunotherapy platform that harnesses sophisticated masters of immune evasion: trypanosomes.